Bilibili Is Maintained at Outperform by Mizuho
Bilibili Analyst Ratings
Daiwa: Bilibili's third-quarter performance may be a key catalyst for the stock price, upgrading the rating to "buy" in one go.
Daiwa Upgrades Bilibili(BILI.US) to Buy Rating, Announces Target Price $28.5
Bilibili Price Target Raised to $22.50/Share From $19.00 by B of A Securities
Bilibili Analyst Ratings
BofA Securities Maintains Bilibili(BILI.US) With Buy Rating
Haitong Int'l: Upgrades bilibili's target price to $20, maintaining a positive outlook on third-quarter earnings.
Major banking rating | Citigroup: Raised bilibili target price to $22, expecting third-quarter performance to meet market expectations
Huaxin Securities: Waiting for the third quarter report to be released, giving a "recommended" rating to the media industry. Recommend focusing on bilibili-W (09626), Qingci Games (06633), etc.
US stocks surge | Bilibili rises more than 7.8% pre-market, institutions raise target price and expect Q3 performance to exceed expectations
Bocom Intl: Raised bilibili-W (09626) target price to 194 Hong Kong dollars, citing 'Three Schemes' game revenue exceeding expectations.
[Brokerage Focus] Bocom Intl raises bilibili (09626) target price by 25.2%, expecting overseas new games to drive growth in overseas game revenue.
Bocom Intl Rating: It is expected that Tencent's third-quarter mobile game revenue will increase by 16%. The high growth in turnover gradually releases the revenue pull.
Bocom Intl Rating: It is expected that Tencent's third-quarter mobile game revenue will increase by 16%. The high growth in turnover gradually releases the revenue pull.
Daiwa Downgrades Bilibili(BILI.US) to Hold Rating
Zephirin Raises Price Target on Bilibili to HK$110 From HK$95, Keeps Strong Sell Medium Risk
U.S. Stock market anomaly | Bilibili (BILI.US) leads the way in the surge of Chinese concept stocks, rising 15% after Goldman Sachs upgraded its rating.
Goldman Sachs: Upgraded Bilibili-W (09626) rating to "buy", target price raised to 176 Hong Kong dollars
U.S. stock abnormal movement | Bilibili pre-market surge exceeds 7.7%, Goldman Sachs short-term factors are positive and raised the target price to $20.